Drug profile · INN
tebentafusp-tebn
KIMMTRAK
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tebentafusp-tebn (KIMMTRAK) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN tebentafusp-tebn
Brand KIMMTRAK
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is tebentafusp-tebn?
tebentafusp-tebn (KIMMTRAK) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for tebentafusp-tebn?
KIMMTRAK is a marketed brand name for tebentafusp-tebn. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tebentafusp-tebn?
tebentafusp-tebn has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.